18.16
-0.81
(-4.27%)
At close: April 16 at 4:00:01 PM EDT
18.71
+0.55
+(3.03%)
Pre-Market: 8:00:09 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHOPAS JAMES GEORGE Officer | Sale | Mar 17, 2025 | 47,955 |
| DELONG MARK JEFFREY Officer | Sale | Feb 11, 2025 | 83,945 |
| DESCHATELETS PASCAL Officer | Sale | Jan 29, 2025 | 1,147,720 |
| EISELE JEFFREY Officer | Sale | Jan 29, 2025 | 55,312 |
| FRANCOIS CEDRIC G Chief Executive Officer | Sale | Jan 29, 2025 | 1,955,120 |
| LEWIS KAREN Officer | Sale | Jan 29, 2025 | 70,251 |
| NICHOLSON NUR Chief Technology Officer | Sale | Jan 29, 2025 | 83,664 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Sale | Jan 29, 2025 | 199,061 |
| TOWNSEND ADAM J Officer | Sale | Jan 29, 2025 | 84,050 |
| WATSON DAVID O General Counsel | Sale | Mar 5, 2025 | 218,866 |
Related Tickers
BPMC Blueprint Medicines Corporation
82.11
+0.81%
BBIO BridgeBio Pharma, Inc.
33.85
-1.14%
CYTK Cytokinetics, Incorporated
39.15
+1.53%
IDYA IDEAYA Biosciences, Inc.
16.18
-4.71%
CRNX Crinetics Pharmaceuticals, Inc.
29.58
-0.27%
SRPT Sarepta Therapeutics, Inc.
53.94
-0.88%
SWTX SpringWorks Therapeutics, Inc.
37.74
+0.40%
AKRO Akero Therapeutics, Inc.
37.44
-1.68%
KYMR Kymera Therapeutics, Inc.
25.02
-1.73%
ALNY Alnylam Pharmaceuticals, Inc.
230.50
-0.19%